Index of /wp-content/uploads/2020/09/

NameLast ModifiedSize
UpParent Directory
FileADDITIONAL-STRENGTH-BIOWAIVER-APPLICATION-FORM.pdf2022-11-11 07:56 204k
FileADVANTAN_PI_CREAM-OINT_ADCOCK-INGRAM08-MAY-1992.pdf2022-11-11 07:56 30k
FileADVERT-ADMIN-SCREENER-X2-BACKLOG-UNIT.pdf2022-11-11 07:56 86k
FileADVERT-MEDICINE-REGISTRATION-OFFICER-Clinical-Evaluation_Post-registration-.pdf2022-11-11 07:57 128k
FileADVERT-MEDICINE-REGISTRATION-OFFICER-PEM_Veterinary.pdf2022-11-11 07:57 126k
FileADVERT-MEDICINE-REGISTRATION-OFFICER-X2-Clinical-Trials.pdf2022-11-11 07:56 126k
FileADVERT-MEDICINE-REGISTRATION-OFFICER-X2-PEM_Post-registration.pdf2022-11-11 07:57 127k
FileADVERT-MEDICINE-REGISTRATION-OFFICER-X2-PEM_Pre-registration.pdf2022-11-11 07:56 127k
FileADVERT-RISK-AND-INTERNAL-AUDIT-MANAGER-.pdf2022-11-11 07:57 120k
FileAgiolax_PI_XIXIA-PHARMACEUTICALS_MCC-Format26-June-2019.pdf2022-11-11 07:56 294k
FileAgiolax_PIL_XIXIA-PHARMACEUTICALS_MCC-Format26-June-2019.pdf2022-11-11 07:57 310k
FileAlphagan-Purite_PI_Allegran_MCC-Format18-October-2016.pdf2022-11-11 07:56 231k
FileAlphagan-Purite_PIL_Allegran_MCC-Format18-October-2016.pdf2022-11-11 07:56 205k
FileArava_PI_Sanofi-Aventis_MCC-Format04-August-2008.pdf2022-11-11 07:57 277k
FileArava_PIL_Sanofi-Aventis_MCC-Format04-August-2008.pdf2022-11-11 07:56 166k
FileASPEN-COLCHICINE_PI_Aspen-Pharamacare_MCC-Format26-November-2015.pdf2022-11-11 07:56 66k
FileASPEN-COLCHICINE_PIL_Aspen-Pharamacare_MCC-Format26-November-2015.pdf2022-11-11 07:56 210k
FileAvelon-IV_PIL_Bayer-Pty-Ltd_MCC-Format02-September-2020.pdf2022-11-11 07:56 164k
FileAvelon-tablet_PIL_Bayer-Pty-Ltd_MCC-format03-September-2020.pdf2022-11-11 07:57 171k
FileAvelon_IV_Avelon-Tablet_PI_Bayer-Pty-Ltd-03-September-2020.pdf2022-11-11 07:56 257k
FileAzoptic_PI_Novartis_MCC-Format30-September-2011.pdf2022-11-11 07:56 41k
FileBacklog-Newsletter-August2020_PR1.pdf2022-11-11 07:56 944k
FileBACTROBAN-TOPICAL_PI_GlaxoSmithKline_MCC-Format04-August-2016.pdf2022-11-11 07:56 178k
FileBACTROBAN-TOPICAL_PIL_GlaxoSmithKline_MCC-Format04-August-2016.pdf2022-11-11 07:57 71k
FileBayquin-IV_PIL_Bayer-Pty-Ltd_MCC-Format03-September-2020.pdf2022-11-11 07:57 165k
FileBayquin-Tablets_Bayquin-IV_PI_Bayer-Pty-Ltd03-September-2020.pdf2022-11-11 07:56 259k
FileBayquin-Tablets_PIL_Bayer-Pty-Ltd_MCC-Format03-September-2020.pdf2022-11-11 07:57 171k
FileBETADINE-DOUCHE-PI-English-only.pdf2022-11-11 07:56 18k
FileBIOEQUIVALENCE-TRIAL-INFORMATION-FORM.pdf2022-11-11 07:56 261k
FileBIOPHARMACEUTICS-CLASSIFICATION-SYSTEM-BCS-BASED-BIOWAIVER-APPLICATION-FORM-.pdf2022-11-11 07:57 288k
FileBONTELVIA_PI_MALEODS-PHARMACEUTICALS_MCC-FORMAT-13-DECEMBER-2019.pdf2022-11-11 07:56 248k
FileBONTELVIA_PIL_MALEODS-PHARMACEUTICALS_MCC-FORMAT-13-DECEMBER-2019.pdf2022-11-11 07:57 286k
FileCilodex-Otic_PI_Novartis_MCC-Format19-October-2007.pdf2022-11-11 07:57 128k
FileCIPROBAY-XR_PI_Bayer-Pty-Ltd_MCC-Format11-August-2020.pdf2022-11-11 07:56 259k
FileCIPROBAY-XR_PIL_Bayer-Pty-Ltd_MCC-Format11-August-2020.pdf2022-11-11 07:56 220k
FileCiprobay_IV_PIL_Bayer-Pty-Ltd_MCC-Format03-September-2020.pdf2022-11-11 07:56 166k
FileCiprobay_Oral_PIL_Bayer-Pty-Ltd_MCC-Format03-September-2020.pdf2022-11-11 07:57 317k
FileCiprobay_range_PI_Bayer-Pty-LTD_MCC-Format03-September-2020.pdf2022-11-11 07:57 319k
FileClindoxyl_PI_GlaxoSmithKline_MCC-Format28-May-2015.pdf2022-11-11 07:57 222k
FileClindoxyl_PIL_GlaxoSmithKline_MCC-Format28-May-2015.pdf2022-11-11 07:56 286k
FileCombigan_PI_Allegran_MCC-Format06-July-2010.pdf2022-11-11 07:57 348k
FileCombigan_PIL_Allegran_MCC-Format06-July-2010.pdf2022-11-11 07:57 316k
FileCosopt_PI_PIL_Mundipharma-Pty-Ltd_MCC-Format15-January-2010.pdf2022-11-11 07:57 601k
FileDecasone-Forte_PI_Pharmacare-limited_MCC-Format13-March-1998.pdf2022-11-11 07:56 19k
FileDifferin-Cream_PI_Galderma_MCC-Format04-July-2014.pdf2022-11-11 07:57 156k
FileDifferin-Gel_PIL_Galderma_MCC-Format04-July-2014.pdf2022-11-11 07:56 155k
FileDifferin_PI_Galderma_MCC-Format04-July-2014.pdf2022-11-11 07:56 319k
FileDIPROSONE_PI_MSDPTYLTD_MCC-FORMAT19-DECEMBER-2017.pdf2022-11-11 07:56 37k
FileDuotrav_PI_Novartis_MCC-Format02-October-2015.pdf2022-11-11 07:56 201k
FileDuotrav_PIL_Novartis_MCC-Format02-October-2015.pdf2022-11-11 07:56 500k
FileELTROXIN_PI_Aspen-Pharma_2020.09.30.pdf2022-11-11 07:57 205k
FileELTROXIN_PIL_Aspen-Pharma_2020.09.30..pdf2022-11-11 07:57 177k
FileEpiduo_PIL_Galderma_MCC-Format17-November-2014.pdf2022-11-11 07:56 60k
FileEPREX_PI_JANSSEN-PHARMACEUTICALS_MCC-FORMAT27-JULY-2012.pdf2022-11-11 07:56 383k
FileEPREX_PIL_JANSSEN-PHARMACEUTICALS_MCC-FORMAT27-JULY-2012.pdf2022-11-11 07:56 159k
FileEuthyrox_PI_Merck_MCC-FormatFebruary-2020.pdf2022-11-11 07:57 124k
FileEuthyrox_PIL_Merck_MCC-FormatFebruary-2020.pdf2022-11-11 07:56 124k
FileEvista_PI_Eli-Lilly_MCC-Format02-March-2012.pdf2022-11-11 07:56 156k
FileEvista_PIL_Eli-Lilly_MCC-Format02-March-2012.pdf2022-11-11 07:56 324k
FileExocin_PI_Allergan-Pharmaceuticals-Pty-Ltd_MCC-Format23-September-2016.pdf2022-11-11 07:56 139k
FileExocin_PIL_Allergan-Pharmaceuticals-Pty-Ltd_MCC-Format23-September-2016.pdf2022-11-11 07:56 46k
FileFosavance_PI_MSD-pty-Ltd_-MCC-Format-11-June-2015.pdf2022-11-11 07:56 181k
FileFosavance_PIL_MSD-pty-Ltd_-MCC-Format-11-June-2015.xps2022-11-11 07:56 498k
FileGanfort_PI_Allergran-Pharmaceuticals-Pty-Ltd_MCC-Format05-May-2020.pdf2022-11-11 07:56 257k
FileGanfort_PIL_Allergran-Pharmaceuticals-Pty-Ltd_MCC-Format05-May-2020.pdf2022-11-11 07:56 345k
FileHumira_PI_AbbVie_MCC-Format-12-May-2020.pdf2022-11-11 07:56 465k
FileHumira_PIL_AbbVie_MCC-Format-12-May-2020.pdf2022-11-11 07:56 557k
FileLioresal_PI_Novartis_MCC-Format15-August-2008.pdf2022-11-11 07:57 554k
FileList-of-licenced-applicant-and-section-21-authorised-ventilators_22092020_vF....2022-11-11 07:57 11k
FileLoceryl_PI_Galderma_MCC-Format25-July-2010.pdf2022-11-11 07:56 105k
FileLoceryl_PIL_Galderma_MCC-Format25-July-2010.pdf2022-11-11 07:56 169k
FileLOTEMAX-OPHTHALMIC-SUSPENSION_PI_Soflens_MCC-Format13-August-2020.pdf2022-11-11 07:56 406k
FileLOTEMAX-OPHTHALMIC-SUSPENSION_PIL_Soflens_MCC-Format13-August-2020.pdf2022-11-11 07:56 325k
FileLumigan_PI_Allergan-Pharmaceuticals_MCC-Format-07-March-2003.pdf2022-11-11 07:56 405k
FileLumigan_PIL_Allergan-Pharmaceuticals_MCC-Format-07-March-2003.pdf2022-11-11 07:56 329k
FileMD022-Application_Clinical_Evaluation_Medical_Device_IVD_v1-01.09.2020.pdf2022-11-11 07:57 673k
FileMD024-FAQs_POC_COVID-19_Antibody_Serology_Test_Kit_10092020_vF.pdf2022-11-11 07:56 174k
FileMD025_Alternative-licensing-and-regulatory-pathway-for-masks_September2020_vF...2022-11-11 07:56 393k
FileMoxibay-IV_PIL_Bayer_MCC-Format09-September-2020.pdf2022-11-11 07:56 166k
FileMoxibay-Tablets_Moxibay-IV_PI_Bayer_MCC-Format-03-September-2020.pdf2022-11-11 07:56 261k
FileMoxibay-Tablets_PIL_Bayer_MCC-Format03-September-2020.pdf2022-11-11 07:56 172k
FileNevanac_PI_Novartis_MCC-Format20-March-2018.pdf2022-11-11 07:57 316k
FileNevanac_PIL_Novartis_MCC-Format20-March-2018.pdf2022-11-11 07:56 150k
FileNIMBEX_PI_Aspen-Pharma_MCC-Format-27-November-1998.pdf2022-11-11 07:56 76k
FilePatanol_PI_Novartis_MCC-Format30-September-2011.pdf2022-11-11 07:57 120k
FilePITE-Extension-Letter_Sep-2020.docx.pdf2022-11-11 07:56 664k
FilePost-Marketing-Reporting-of-ADRs-to-Human-Medicines-in-SA_Version-7showing-ch...2022-11-11 07:56 209k
FileRelestat_PI_Allergan-Pharmaceuticals-Pty-Ltd_MCC-Format20-July-2018.pdf2022-11-11 07:56 305k
FileRelestat_PIL_Allergan-Pharmaceuticals-Pty-Ltd_MCC-Format20-July-2018.pdf2022-11-11 07:56 331k
FileRevellex_PI_JANSSEN-PHARMACEUTICA_MCC-Format30-June-2016.pdf2022-11-11 07:56 589k
FileRevellex_PIL_JANSSEN-PHARMACEUTICA_MCC-Format30-June-2016.pdf2022-11-11 07:56 363k
FileStelara_PI_Janssen-Pharmaceutica_MCC-Format17-September-2019.pdf2022-11-11 07:57 664k
FileStelara_PIL_Janssen-Pharmaceutica_MCC-Format17-September-2019.pdf2022-11-11 07:57 993k
FileStrepsils-Intensive_PI_Reckitt-Benckiser_MCC-Format25-April-2003.pdf2022-11-11 07:56 426k
FileTimoptol-PI-PIL-Mundipharma-Pty-Ltd23-Novmber-2019.pdf2022-11-11 07:57 398k
FileTobradex_PI_Novartis_MCC-Format-17-February-2017.pdf2022-11-11 07:57 152k
FileTobradex_PIL_Novartis_MCC-Format-17-February-2017.pdf2022-11-11 07:56 52k
FileTravatan_PI_Novartis_MCC-Format06-June-2014.pdf2022-11-11 07:56 318k
FileTravatan_PIL_Novartis_MCC-Format06-June-2014.pdf2022-11-11 07:56 334k
FileTrusopt-PI-PIL-Mundipharma-Pty-Ltd.pdf2022-11-11 07:56 766k
FileVividrin-Eye-Drops_PI_Soflens-Pty-Ltd_MCC-Format13-August-2020.pdf2022-11-11 07:56 302k
FileXalacom_PI_Pfizer_MCC-Format05-June-2019.pdf2022-11-11 07:56 178k
FileXalacom_PIL_Pfizer_MCC-Format05-June-2019.pdf2022-11-11 07:57 158k
FileXALATAN_PI_Pfizer_MCC-Format-07-June-2019.pdf2022-11-11 07:56 156k
FileXALATAN_PIL_Pfizer_MCC-Format-07-June-2019.pdf2022-11-11 07:57 153k
FileZaditen_PI_Adcock-Ingram_MCC-format07-July-2003.pdf2022-11-11 07:56 13k
FileZOLEDRONIC-ACID_PI_CIPLA_MCC-Format23-April-2015.pdf2022-11-11 07:56 324k
FileZOLEDRONIC-ACID_PIL_CIPLA_MCC-Format23-April-2015.pdf2022-11-11 07:56 211k
FileZYLOPRIM_PI_Aspen-Pharma_MCC-Format30-November-1993.pdf2022-11-11 07:56 43k
FileZYLOPRIM_PIL_Aspen-Pharma_MCC-Format30-November-1993.pdf2022-11-11 07:56 142k
Proudly Served by LiteSpeed Web Server at www.sahpra.org.za Port 443